Director – Professor Louis Schofield
Professor Louis Schofield is an International Research Scholar of the Howard Hughes Medical Institute and co-founder of Ancora Pharmaceuticals Inc. He shares the Directorship of QTHA with his ongoing research work at the Walter and Eliza Hall Institute. A recognised authority in the immunology and pathogenesis of infectious diseases, he has research programs covering basic molecular sciences, product development and commercialisation, epidemiology and public health. His approach to malaria has resulted in promising vaccine development programs and he is involved in clinical trials in Papua New Guinea and Africa. He has published several key articles, including in Nature and Science, and has received over 4,000 citations to date.
Deputy Director – Professor Suresh Mahalingam
As well as holding the Deputy Directorship of QTHA, Suresh Mahalingham is Professor of Virology at the Institute for Glycomics, Griffith University and Group leader of the Emerging Viruses and Inflammation Research Group. His research interests include investigating mechanisms of; how mosquito-borne viruses cause arthritis; how respiratory viruses exacerbates asthma; how viruses evade the immune system; investigating viral factors that enable arboviruses to adapt in mosquitos; and designing and developing antivirals against viruses.
Chief Operating Officer - Dr Andrew Johnson
Dr Andrew Johnson is the Chief Operating Officer for the Australian Institute of Tropical Health and Medicine (AITHM) at James Cook University and the Queensland Tropical Health Alliance (QTHA). Andrew has over twenty years' experience in research and research management, He was previously the CEO of the Western Research Institute. Prior to that role he was the Director of Research Development at The University of Newcastle. With an academic background at multiple institutions including UNE, Newcastle